Focetria

A/H1N1 swine-origin influenza vaccine, monovalent · Novartis Vaccines and Diagnostics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Focetria, covering 2016-02-11 to 2016-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects [Phase 2]

See pricing